Effects of antidepressants on cytokine production and actions

Brain, Behavior, and Immunity

Volumn 16, Issue 5, 2002, Pages 569-574

  Castanon, Nathalie ^a   Leonard, Brian E ^b   Neveu, Pierre J ^a   Yirmiya, Raz ^c  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Animal models; Antidepressants; Cytokines; Depression

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CLOMIPRAMINE; CYCLIC AMP; FLUOXETINE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMIPRAMINE; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RECOMBINANT CYTOKINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE; CYTOKINE;

ANHEDONIA; ANIMAL BEHAVIOR; ANTIINFLAMMATORY ACTIVITY; BEHAVIOR; BRAIN REGION; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; ILLNESS BEHAVIOR; IMMUNOREACTIVITY; INFECTION; MONOAMINERGIC SYSTEM; MOOD DISORDER; NEGATIVE FEEDBACK; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSYCHOPHYSIOLOGY; SEROTONIN METABOLISM; SIDE EFFECT; TREATMENT OUTCOME; ANIMAL; DISEASE MODEL; IMMUNOLOGY; MENTAL STRESS; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; CYTOKINES; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HUMANS; STRESS, PSYCHOLOGICAL;

EID: 0036429004     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(02)00008-9     Document Type: Conference Paper

References (43)

1. Aloe, L., Properzi, F., Probert, L., Akassoglou, K., Kassiotis, G., Micera, A., & Fiore, M. (1999). Learning abilities, NGF and BDNF brain levels in two lines of TNF-α transgenic mice, one characterized by neurological disorders, the other phenotypically normal. Brain Res., 840, 125-137.
2. Barden, N. (1999). Regulation of corticosteroid receptor gene expression in depression and antidepressant action. J. Psychiatry Neurosci., 24, 25-39.
3. Calabrese, J. R., Skwerer, R. G., Barna, B., Gulledge, A. D., Valenzuela, R., Butkus, A., Subichin, S., & Krupp, N. E. (1986). Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res., 17, 41-47.
4. Capuron, L., & Ravaud, A. (1999a). Prediction of the depressive effects of interferon alfa by the patient's initial affective state. New Eng. J. Med., 340, 1370.
5. Capuron, L., & Ravaud, A. (1999b). More on the depressive effects of interferon alfa. New Eng. J. Med., 340, 849-850.
6. Castanon, N., Bluthé, R. M., & Dantzer, R. (2001). Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1b in the rat. Psychopharmacology, 154, 50-60.
7. Castanon, N., Konsman, J.P., Médina, C., Chauvet, N. & Dantzer, R. (2002). Chronic treatment with the atypical antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and corticosterone secretion, Psychoneuroendocrinology, in press.
8. Connor, T., Harkin, A., Kelly, J., & Leonard, B. E. (2000). Olfactory bulbectomy provokes a suppression of interleukin-1β and TNF-α production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment. Neuroimmunomodulation, 7, 27-35.
9. Dantzer, R. (2001). Cytokine-induced sickness behavior: Where do we stand? Brain Behav. Immun., 15, 7-24.
10. Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999). Cytokines and depression: Fortuitous or causative association? Mol. Psychiatry, 4, 328-332.
11. Deleplanque, B., & Neveu, P. J. (1995). Immunological effects of neuropsychiatric substances. In M. Guenounou (Ed.), Forum on Immunomodulators (pp. 287-302). Paris: John Libbey Eurotext.
12. Goujon, E., Parnet, P., Aubert, A., Goodall, G., & Dantzer, R. (1995). Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1b in mice. Am. J. Physiol., 269, R154-R159.
13. Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmacher, T. (1999). Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. J. Psychiatry Res., 33, 407-418.
14. Hindmarch, I. (2001). Expanding the horizons of depression: Beyond the monoamine hypothesis. Hum. Psychopharmacol., 16, 203-218.
15. Holsboer, F. (1999). The rationale for corticotropin-releasing hormone receptor (CHR-R) antagonists to treat depression and anxiety. J. Psychiatr. Res., 33, 181-214.
16. Jacobs, B. L., van Praag, H., & Gage, F. H. (2000). Adult brain neurogenesis and psychiatry: A novel theory of depression. Mol. Psychiatry, 5, 262-269.
17. Kelly, J. P., Wrynn, A. S., & Leonard, B. E. (1997). The olfactory bulbectomized rat as a model of depression: An update. Pharmacol. Ther., 74, 299-316.
18. Kent, S., Bluthé, R. M., Kelley, K. W., & Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends in Pharmacol. Sci., 13, 24-28.
19. Konan, K. W., & Taylor, M. W. (1996). Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene. J. Biol. Chem., 271, 19140-19145.
20. Kubera, M., Holan, V., Mathison, R., & Maes, M. (2000a). The effect of repeated amitryptiline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology, 25, 758-797.
21. Kubera, M., Kenis, G., Bosmans, E., Scharpé, S., & Maes, M. (2000b). Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-γ and interleukin-10. Neuropsychopharmacology, 23, 89-98.
22. Kubera, M., Symbirtsev, A., Basta-Kaim, A., Borycz, J., Roman, A., Papp, M., & Claesson, M. (1996). Effect of chronic treatment with imipramine on interleukin-1 and interleukin-2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol., 20, 429-438.
23. Kubera, M., Simbirtsev, A., Mathison, R., & Maes, M. (2000c). Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiatr. Res., 96, 255-266.
24. Leonard, B. E. (2001a). Changes in the immune system in depression and dementia: Causal or co-incidental effects? Int. J. Devl. Neurosci., 19, 305-312.
25. Leonard, B. E. (2001b). The immune system, depression and the action of antidepressants. Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 25, 767-780.
26. Linthorst, A. C. E., & Reul, J. M. H. M. (1999). Inflammation and brain function under basal conditions and during long-term elevation of brain corti-cotropin-releasing hormone levels. Adv. Exp. Med. Biol., 461, 129-152.
27. Maes, M. (2001). The immunoregulatory effects of antidepressants. Hum. Psychopharmacol., 16, 95-103.
28. Maes, M., Smith, R., & Charpé, S. (1995). The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology, 20, 111-116.
29. Maier, S. F., & Watkins, L. R. (1995). Intracerebroven-tricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res., 695, 279-282.
30. Montgomery, S. A. (1994). Antidepressants in long-term treatment. Annu. Rev. Med., 45, 447-457.
31. Neveu, P. J., & Castanon, N. (1999). Is there evidence for an effect of antidepressant drugs on immune function? Adv. Exp. Med. Biol., 461, 267-281.
32. Norbiato, G., Bevilacqua, M., & Vago, T. (1997). Glucocorticoids and the immune system in AIDS. Psychoneuroendocrinology, 22, S19-S25.
33. Shen, Y., Connor, T., Nolan, Y., Kelly, J., & Leonard, B. E. (1999). Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci., 17, 1773-1786.
34. Song, C., & Leonard, B. E. (1994). SSRI's reverse the impairment in behaviour, neurotransmitter and immune function in the olfactory bulbectomised rat. Hum. Psychopharmacol., 9, 135-146.
35. Suzuki, E., Shintani, F., Kanba, S., Asai, M., & Nakaki, T. (1996). Induction of interleukin-1β and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain. Neurosci. Lett., 215, 201-204.
36. Willner, P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology, 134, 319-329.
37. Xia, Z., De Pierre, J., & Nassberger, L. (1996). Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-α in T cells. Immunopharmacology, 34, 27-37.
38. Yaron, I., Shirazi, L., Judovich, R., Levartovsky, D., Caspi, D., & Yaron, M. (1999). Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum., 42, 2561-2568.
39. Yirmiya, R. (1996). Endotoxin produces a depressive-like episode in rats. Brain Res., 711, 163-174.
40. Yirmiya, R. (2000). Depression in medical illness. The role of the immune system. West J. Med., 173, 333-336.
41. Yirmiya, R., Pollak, Y., Barak, O., Avitsur, R., Ovadia, H., Bette, M., Weihe, E., & Weidenfeld, J. (2001). Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology, 24, 531-544.
42. Yirmiya, R., Pollak, Y., Morag, M., Reichenberg, A., Barak, O., Avitsur, R., Shavit, Y., Ovadia, H., Weidenfeld, J., Morag, A., Newman, M. E., & Pollmächer, T. (2000). Illness, cytokines and depression. Ann. NY Acad. Sci., 917, 478-487.
43. Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., & Ovadia, H. (1999). Cytokines, "depression due to a general medical condition," and antidepressant drugs. Adv. Exp. Med. Biol., 461, 283-316.